Clinical Trials in Baltimore

Showing 2681-2700 of 11,213 trials

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

NCT06568692

This is an adaptive Phase 2, open-label, randomized, multi-center study evaluating up to 2 regimens of PCS6422 with capecitabine (Cap) vs. standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy and safety of PCS6422 + Cap as a treatment option for patients with advanced or metastatic breast cancer who are not eligible for anthracycline- or taxane-containing therapies, or other available therapies, including PD-1 or PARP inhibitors.

Breast CancerTNBC - Triple-Negative Breast CancerHER2-negative Breast Cancer

Processa Pharmaceuticals90 participantsStarted Oct 2024

Tucson, Arizona, United States • Los Angeles, California, United States • Oxnard, California, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

NCT03642067

The purpose of this study is to evaluate the safety and clinical activity of nivolumab and relatlimab in patients with metastatic or locally advanced microsatellite stable (MSS) colorectal cancer.

Microsatellite Stable (MSS) Colorectal AdenocarcinomasColorectal Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins59 participantsStarted Feb 2019

Baltimore, Maryland, United States

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Find Trials by Condition in Baltimore

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

RemI for Post-Bariatric Surgery Weight Regain

EluPro Antibiotic-Eluting BioEnvelope Registry

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

A Study of E7820 in People With Bone Marrow (Myeloid) Cancers

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment